One of the best ways to judge the authenticity of a supplement, or any product for that matter, is to take a close look at the research standing behind it. Many companies don’t see the need to invest in real scientific research and continue to inundate the market with less-than satisfactory products. So what is real research? Here are a few ways research has been defined:

All of these definitions are indeed true, and when passion for the research is also incorporated into the process, revolutionary products like GAKIC^® are created. Dr. Bruce R. Stevens is definitely one of those passionate individuals. He is a highly decorated and respected scientist with true passion not only for science but also for the complete accuracy of his work.

DR. BRUCE R. STEVENS is a Professor in the College of Medicine at the University of Florida, Department of Physiology and Functional Genomics. He also holds faculty appointments in the Department of Surgery and the Department of Applied Physiology & Kinesiology. His background includes research at UCLA School of Medicine, NASA and Illinois State University. Dr. Stevens has been a member of many professional associations such as the American Physiological Society, the International Society for Amino Acid Research and the American College of Sports Medicine.

With more than 140 published research papers, book chapters, review papers and abstracts, Dr. Stevens is a highly experienced and internationally respected expert in his field. His work on GAKIC has decisively changed the face of athletic performance.

Below you will find full study abstracts for some of the research conducted on the one-of-a-kind GAKIC formula.

PURPOSE: The purpose of this study was to quantify the effects of a metabolic treatment on human muscle dynamic performance (strength, work, and fatigue) measured under conditions of acute, exhaustive high-intensity anaerobic isokinetic exercise.

METHODS: Unilateral prefatigue and postfatigue peak torque and work values were measured in the quadriceps femoris of 13 subjects using a computer-controlled isokinetic dynamometer, over a 23-d interval. The two experimental treatments were: 1) a glycine and L-arginine salt of alpha-ketoisocaproic acid calcium (key ingredients in GAKIC); and 2) isocaloric sucrose (control). Based on a randomized double-blind cross-over repeated measures design, measurements were made before and during an exhaustive anaerobic fatigue protocol to calculate a Fatigue Resistance Index (FRI = [peri-exhaustion torque]÷[baseline peak torque]), as well as total work.

RESULTS: The FRI and total work for each of the exhaustion sets measured at 0, 5, and 15 min after the oral treatment of the key ingredients in GAKIC were greater than values obtained for isocaloric control treatment (P < 0.02). Treatment of the key ingredients in GAKIC increased the mean resistance to fatigue (FRI) up to 28% over isocaloric control. Overall gain in total muscle work attributable to GAKIC's key ingredient was 10.5 0.8% greater than control, sustained for at least 15 min. After 24 h, both the key ingredients in GAKIC and control concentric forces returned to the same absolute values (P < 0.05): mean FRI = 0.42 0.05 and mean total work = 4600 280 J. There were no significant differences attributable to random order of testing.

CONCLUSIONS: Compared with isocaloric carbohydrate, the oral treatment for the key ingredients in GAKIC increased muscle torque and work sustained during intense acute anaerobic dynamic exercise; additionally, it increased overall muscle performance by delaying muscle fatigue during the early phases of anaerobic dynamic exercise.

PURPOSE: The purpose of this study was to determine the effect of glycine-arginine-alpha-ketoisocaproic acid (key ingredients in GAKIC) supplementation on repeated bouts of anaerobic cycling performance.

METHODS: Ten men completed a randomized, double-blinded, placebo-controlled exercise protocol of two sessions separated by 7 d. Plasma lactate was analyzed in blood collected 45 min before exercise (REST) and 5 min postexercise (POST). Subjects consumed either the key ingredients in GAKIC or placebo (PLC) during a 45-min period between the REST and exercise. Mean power, peak power, and fatigue values were assessed from five supramaximal, 10-s cycle ergometer sprints, separated by 1-min rest intervals. Data was analyzed using repeated measures ANCOVA.

RESULTS: A significant treatment x time interaction (P = 0.039) was observed for the change in mean power output over the five sprints between the key ingredients in GAKIC and PLC treatments. Post hoc analyses revealed a greater retention of mean power (P = 0.038) between sprints 1 and 2 after the key ingredients in GAKIC (-1 9 W) versus PLC treatment (-47 18 W). No other performance variables differed between PLC and GAKIC's key ingredient. POST lactate was increased (P < 0.001) above REST, but there was no difference between treatments (P = 0.936).

CONCLUSION: These data support an ergogenic effect of the key ingredients in GAKIC for attenuating the decline in mean power during repeated bouts of supramaximal exercise.

The study conducted by researchers at Truman State University was an independent study that confirmed the results of Dr. Stevens’ study. The results of that study further solidified that Dr. Stevens and his University of Florida team had come across the next major breakthrough for the sports community.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.